Bio-Techne Expands AI-Engineered Designer Protein Portfolio for Advanced Cell Research

New R&D Systems™ Proteins Enhance Cell Therapy, Stem Cell and Organoid Workflows

Bio-Techne has expanded its R&D Systems™ AI-Engineered Designer Protein Portfolio with a new range of engineered signaling proteins developed to improve performance in advanced cell culture applications. The expanded portfolio leverages artificial intelligence-assisted protein design to create proteins with enhanced stability, activity and consistency, helping researchers improve reproducibility across cell therapy, stem cell and organoid research workflows.

Improving Performance in Cell Culture

Advanced cell-based research requires highly reliable growth factors and cytokines that maintain consistent biological activity throughout experimental workflows. Bio-Techne's AI-engineered proteins are designed to address common challenges such as variability, reduced protein stability and scalability, enabling researchers to achieve more dependable results during cell expansion and differentiation.

Supporting Next-Generation Therapeutic Development

The expanded portfolio includes newly engineered fibroblast growth factors (FGFs) and interleukin proteins optimized for applications involving stem cell maintenance, organoid development and cell therapy manufacturing. These proteins are designed to improve critical performance characteristics, helping streamline workflows from early-stage research through process development and large-scale production.

Accelerating Innovation Through AI-Driven Protein Engineering

Artificial intelligence is increasingly being applied to protein engineering to develop biomolecules with improved functionality. By combining computational protein design with decades of expertise in life science reagents, Bio-Techne continues expanding its portfolio of research tools that support biotechnology innovation, regenerative medicine and advanced therapeutic discovery.

Key Features

• Expanded R&D Systems™ AI-Engineered Designer Protein Portfolio

• AI-assisted protein engineering technology

• Enhanced protein stability and biological activity

• Improved reproducibility in cell culture workflows

• Heat-stable and hyperactive engineered proteins

• Optimized for stem cell and organoid research

• Supports cell therapy process development

• Designed for scalable research and biomanufacturing applications

Applications

• Cell therapy research

• Stem cell culture

• Organoid development

• Regenerative medicine

• Biopharmaceutical process development

• Drug discovery research

• Advanced cell biology studies

• Biotechnology laboratories

Advancing AI-Driven Life Science Research

As cell therapies and regenerative medicine continue advancing, researchers require biological reagents that deliver consistent performance from discovery through manufacturing. Bio-Techne's expanded AI-Engineered Designer Protein Portfolio demonstrates how artificial intelligence can enhance protein design, providing researchers with more robust tools for accelerating scientific discovery and the development of future therapeutic technologies.